397
Views
4
CrossRef citations to date
0
Altmetric
Letters to the Editor

Efficacy and toxicity of a rituximab and methotrexate based regimen (GMALL B-ALL/NHL 2002 protocol) in high risk diffuse large cell B-cell lymphoma patients as a first line treatment

, , , , &
Pages 1723-1726 | Received 25 Mar 2015, Accepted 19 Oct 2015, Published online: 16 Mar 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Haifeng Sun, Li Xue, Yahuan Guo, Jianqiang Du, Kejun Nan & Ming Li. (2022) Global, regional and national burden of non-Hodgkin lymphoma from 1990 to 2017: estimates from global burden of disease study in 2017. Annals of Medicine 54:1, pages 633-645.
Read now

Articles from other publishers (3)

Katharina Kriegsmann, Maurizio Wack, Mark Kriegsmann, Martin Cremer, Thomas Bruckner, Anthony D. Ho, Patrick Wuchter & Mathias Witzens-Harig. (2018) Selective contrast-enhanced computed tomography is appropriate in diffuse large B-cell lymphoma therapy response assessment. European Journal of Haematology 101:5, pages 613-619.
Crossref
Meenu Angi, Vandana Kamath, S. Yuvarani, J. Meena, Usha Sitaram, Marie Therese Manipadam, Sukesh Nair, Abhijeet Ganapule, N.A. Fouzia, Aby Abraham, Auro Viswabandya, B. Poonkuzhali, Biju George, Vikram Mathews, Alok Srivastava & Vivi M. Srivastava. (2017) The t(8;14)(q24.1;q32) and its variant translocations: A study of 34 cases. Hematology/Oncology and Stem Cell Therapy 10:3, pages 126-134.
Crossref
Harilal Patel, Poonam Giri, Ashok Ghoghari, Prashant Delvadia, Muzeeb Syed & Nuggehally R. Srinivas. (2017) Review of the bioanalytical methods for the determination of methotrexate and its metabolites in in vitro , preclinical and clinical studies: Case studies and perspectives . Biomedical Chromatography 31:1, pages e3849.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.